Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the world's first human clinical trial for a vaccine targeting the Bundibugyo strain of the Ebola virus.
The obvious questions
What is being tested?
A vaccine targeting the Bundibugyo strain of the Ebola virus.
Who is conducting the trial?
The Oxford Vaccine Group, with support from CEPI.
Where is the trial taking place?
The trials are beginning in the UK, with Uganda identified as a significant location for the broader vaccine effort.
🌍 Language by language
This story first appeared in 🇧🇷 Portuguese coverage — 8.1 hours before headlinez.news detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
The story so far
The Oxford Vaccine Group has initiated testing for a new vaccine candidate intended to combat the Bundibugyo ebolavirus. This trial represents the first instance of human testing for a vaccine specific to this strain, occurring amid an ongoing Ebola outbreak in Congo. Coverage from outlets including Reuters, Bloomberg, the BBC, and Sky News emphasizes that the project is supported by CEPI.
Reports also identify Uganda as a location of significance in the development and testing process. The University of Oxford has officially confirmed its involvement in the response. Future updates will monitor the progression of the human trial phases.
Information regarding the duration of the study or specific efficacy results is not yet available in current coverage.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Coverage (10)
- First human trial of Bundibugyo Ebola vaccine begins The Seattle Times · 48d ago
- First Human Trial of Bundibugyo Ebola Vaccine Begins as Congo Outbreak Continues Bloomberg.com · 48d ago
- First Human Trial of Bundibugyo Ebola Vaccine Begins Bloomberg.com · 48d ago
- Oxford Begins World’s First Human Trial of Bundibugyo Ebola Vaccine as Congo Outbreak Continues Bloomberg.com · 48d ago
- The Ugandan city where the race for a new Ebola vaccine will be won or lost The Telegraph · 48d ago
- Oxford's Bundibugyo ebolavirus response University of Oxford · 48d ago
- Human trials of new Ebola vaccine set to begin in UK Sky News · 48d ago
- CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group CEPI · 48d ago
- UK starts first vaccine trial, eight weeks into Ebola emergency BBC · 48d ago
- Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 48d ago
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
From around our network
- Why the DR Congo Ebola Outbreak Keeps Breaking Records daybreakwire.com
Related trends
Uganda declares end to Ebola outbreak
Uganda has officially declared its latest Ebola outbreak over, even as neighboring Congo continues to struggle with the virus.
Measles Is Becoming So Common That Treatments May Soon Be Needed
U.S. measles cases have reached a 35-year high, prompting urgent vaccine pushes as outbreaks surpass previous annual totals.
First person gets new experimental vaccine for Ebola
The first human participant has received an experimental vaccine targeting the Bundibugyo ebolavirus strain as clinical trials launch in the DRC.
‘There’s no salary’: DRC health workers tell of hardship as Ebola spreads
Ebola cases approach 3,000 in the Democratic Republic of Congo as labor strikes and ongoing violence hinder containment efforts.
An HIV vaccine is within reach thanks to mRNA
Recent advancements in mRNA technology are generating renewed optimism for the development of a viable HIV vaccine.
Rivers of magma once bubbled beneath crust of Mars, research suggests
New scientific research reveals evidence of ancient underground magma rivers on Mars, prompting fresh discussion about the planet's geological history.